Impact of a novel prioritization framework on clinician-led oncology drug submissions.

MLA

Keech, J., et al. “Impact of a Novel Prioritization Framework on Clinician-Led Oncology Drug Submissions.” Current Oncology, vol. 26, no. 2, Apr. 2019, pp. e155–61. EBSCOhost, https://doi.org/10.3747/co.26.4501.

APA

Keech, J., Beca, J., Eisen, A., Kennedy, E., Kim, J., Kouroukis, C. T., Darling, G., Ferguson, S. E., Finelli, A., Petrella, T. M., Perry, J. R., Chan, K., & Gavura, S. (2019). Impact of a novel prioritization framework on clinician-led oncology drug submissions. Current Oncology, 26(2), e155–e161. https://doi.org/10.3747/co.26.4501

Chicago

Keech, J., J. Beca, A. Eisen, E. Kennedy, J. Kim, C. T. Kouroukis, G. Darling, et al. 2019. “Impact of a Novel Prioritization Framework on Clinician-Led Oncology Drug Submissions.” Current Oncology 26 (2): e155–61. doi:10.3747/co.26.4501.